Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)

Q: What does CUSIP 52886X107 represent in this 13F holders report?

CUSIP 52886X107 is the security identifier for LXEO - Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held LXEO - Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q2 2024?

57 institutional investors reported LXEO - Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q2 2024. Use the holders table for investor-level position and value details.

CUSIP: 52886X107

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 74,507,639
Total 13F shares: 26,566,622
Share change: +3,439,176
Total reported value: $426,105,401
Reported price per share: $16.04
Number of holders: 57
Value change: +$55,254,655
Number of buys: 37
Number of sells: 21

Security key

52886X107

Report period

Q2 2024

Institutions

Top holders

LXEO full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2024 Previous quarter: Q1 2024 Lexeo Therapeutics, Inc. SEC filings Lexeo Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 52886X107

Newer quarter: Q3 2024 Previous quarter: Q1 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of LXEO - Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

EVENTIDE ASSET MANAGEMENT...

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2024

13F Lead comparable stake: 4.5% Showing 1-6 of 15 holder rows.

Rank 1 holder

EVENTIDE ASSET MANAGEMENT, LLC

13F

Ownership: 4.5%
Position: $52.83M

13F

Rank 2 holder

JANUS HENDERSON GROUP PLC

13F

Ownership: 3.4%
Position: $39.8M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
EVENTIDE ASSET MANAGEMENT, LLC	13F Company 13F	4.5%	$52,828,225 3,369,147 shares	—	31 Mar 2024
JANUS HENDERSON GROUP PLC	13F Company 13F	3.4%	$39,802,357 2,540,785 shares	—	31 Mar 2024
D1 Capital Partners L.P.	13F Company 13F	3.4%	$39,303,598 2,506,607 shares	—	31 Mar 2024
CITADEL ADVISORS LLC	13F Company 13F	3.4%	$38,884,020 2,502,981 shares	—	31 Mar 2024
Omega Fund Management, LLC	13F Company 13F	3.2%	$36,940,575 2,355,904 shares	—	31 Mar 2024
Novo Holdings A/S	13F Company 13F	2.2%	$25,688,513 1,638,298 shares	—	31 Mar 2024

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

26,566,622

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend